UTAH MEDICAL PRODUCTS (UTMD) director reports 150-share bona fide stock gift
Rhea-AI Filing Summary
UTAH MEDICAL PRODUCTS INC director Paul O. Richins reported an indirect bona fide gift of 150 shares of Common Stock. The gift was valued at $73.07 per share based on the Form 4 disclosure. After this disposition, indirect holdings total 20,765 shares.
These shares are held through various accounts and entities, including a spouse's IRA, a son's account, the reporting person's IRA, and the Richins Family Trust, as described in the footnote. The transaction reflects a non-market gift transfer rather than an open-market sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 150 | $73.07 | $11K |
Footnotes (1)
- [object Object]
Key Figures
Key Terms
Bona fide gift financial
IRA financial
Richins Family Trust financial
indirect financial
FAQ
What insider transaction did Paul O. Richins report for UTAH MEDICAL PRODUCTS INC (UTMD)?
Paul O. Richins reported a bona fide gift of 150 shares of UTAH MEDICAL PRODUCTS INC Common Stock. The transaction is coded “G” on Form 4, indicating a gift disposition rather than a market sale or purchase.
How are Paul O. Richins’ indirect UTMD holdings structured?
Indirect UTMD holdings include 1,245 shares in a spouse's IRA, 222 shares held by a son, 500 shares in the reporting person's IRA, and 18,798 shares held by the Richins Family Trust, according to the footnote.
Does the reported UTMD transaction involve an open-market sale or purchase?
No, the UTMD transaction is a bona fide gift, not an open-market trade. The Form 4 uses transaction code “G” and describes the action as a gift transfer, which typically carries limited signaling about market views.